While ectopic G0S2 binding to nucleolin could explain the reduced survival we observed in CML cells in vitro, it cannot play a role in human HSCs because G0S2 is not expressed. This evidence concerns the gene NUCLEOLIN and chronic myelogenous leukemia, BCR-ABL1 positive.